Mark Wilterding
Chief Financial Officer · 4 filings · Latest: Sep 5, 2026
RxSight, Inc.
| Ticker | Owner | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total | SEC Filing |
|---|---|---|---|---|---|---|---|---|---|
RXST | Wilterding Mark | — | Sep 2, 2026 | Proposed Sale | $6.96 | 7,765 | $54.0K | — | |
RXST | Mark Wilterding | Chief Financial Officer | Sep 2, 2026 | Sale | $6.96 | 7,765 | $54.0K | 25,049 | |
RXST | Mark Wilterding | Chief Financial Officer | Aug 31, 2026 | Option Exercise | — | 20,441 | — | 32,814 | |
RXST | Mark Wilterding | Chief Financial Officer | Feb 28, 2026 | Option Exercise | — | 20,441 | — | 20,441 |